*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Elatinib intermediates are key synthetic precursors for the development of <strong>Elatinib</strong>, a selective EGFR inhibitor. These compounds typically involve complex heterocyclic construction and chiral synthesis steps. The primary intermediate often corresponds to CAS 287905-47-9, with molecular formula C<sub>19</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Essential building blocks for large-scale production of targeted cancer therapies.</li>
<li><strong>R&D Processes:</strong> Used in lead optimization and structure-activity relationship (SAR) studies.</li>
<li><strong>Clinical Trials:</strong> Sourced for GMP-grade synthesis of investigational new drugs (IND).</li>
</ul>
<h3>Precautions</h3>
<p>Strict adherence to GMP standards is required during handling. Store in a cool, dry, well-ventilated area away from incompatible oxidizers. Personnel must wear appropriate PPE due to potential toxicity and skin irritation risks associated with organic halides.</p>